Computed tomography follow-up after elective proximal aortic surgery: Less is more?


Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
07 2022
Historique:
received: 18 12 2021
revised: 16 03 2022
accepted: 07 04 2022
pubmed: 19 4 2022
medline: 31 5 2022
entrez: 18 4 2022
Statut: ppublish

Résumé

The added value of computed tomography (CT) follow-up after elective proximal aortic surgery is unclear. We evaluated the benefit of CT follow-up by assessing the incidence of aorta-related complications and reinterventions detected during routine CT follow-up. Data on 314 patients undergoing first time elective proximal aortic surgery between 2000 and 2015 were collected. The primary study end points were aorta-related complications and reinterventions, detected during routine CT follow-up. Secondary study endpoints included all aorta-related complications and reinterventions, irrespective of the mode of detection and survival. Median CT follow-up time was 6.8 (IQR 4.1-9.8) years, during which a total of 1303 routine follow-up CT-scans (median 4, IQR 3-5) were performed. During CT follow-up, aorta-related complications were detected in 18 (5.7%) patients, of which 6 (1.6%) underwent reintervention. In total, 28 aorta-related complications were observed in 23 (7.3%) patients, of which 9 led to reintervention. In order to detect 1 aorta-related complication leading to reintervention, 218 routine follow-up CT-scans were required. The unadjusted and EuroSCORE II adjusted hazard ratios of not undergoing CT follow-up on mortality were 1.260 (95% CI 0.705-2.251) and 0.830 (95% CI 0.430-1.605), respectively. Following first time elective proximal aortic surgery, aorta-related complications are uncommon, are not always detected during CT follow-up and, if detected, often do not result in reintervention. Therefore, a more conservative CT follow-up protocol could be considered in selected patients to reduce lifetime radiation burden and health care costs.

Identifiants

pubmed: 35436505
pii: S0002-8703(22)00068-0
doi: 10.1016/j.ahj.2022.04.003
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-75

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Delano J de Oliveira Marreiros (DJ)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: d.j.de_oliveira_marreiros@lumc.nl.

Anton Tomšič (A)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Thomas J van Brakel (TJ)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Jaap F Hamming (JF)

Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Arthur J H A Scholte (AJHA)

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Jesper Hjortnaes (J)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Robert J M Klautz (RJM)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH